Form D · Biotechnology
Polus International Corp
Los Angeles, CA · CIK 0001691574
Offering snapshot reported Dec 12, 2016 · SEC filing
- Reported sold
- $2.05K Offering amount: $2.05K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 29, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 12, 2016 | Initial | $2,050 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-276077
Source: Form D, filed Dec 12, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James I Bang | Director |
| Eui Kyung Cho | Executive |
| Jin Ha Chung | Director, Executive |
| Sung Mee Chung | Executive |
| Seungheon Nam | Director |
| Joo Ho Park | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3150 Wishire Blvd. Ph 15
Los Angeles, CA, 90010
Los Angeles, CA, 90010